David Y. Liu
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Y. Liu
The proxy statement of Protagonist Therapeutics, Inc reports total compensation of $2,070,827 for David Y. Liu in fiscal 2021, including a base salary of $455,000. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Protagonist Therapeutics, Inc (PTGX)
Proxy statement
Start not stated–2022-04-13
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Protagonist Therapeutics, Inc (PTGX) | Chief Research and Development Strategy Officer | $455,000 | $2,070,827 |
| 2020 | Protagonist Therapeutics, Inc (PTGX) | Chief Research and Development Strategy Officer | $441,300 | $1,071,849 |
| 2019 | Protagonist Therapeutics, Inc (PTGX) | Chief Scientific Officer and Head of Discovery and Pre-Clinical Development | $428,450 | $1,199,598 |
| 2018 | Protagonist Therapeutics, Inc (PTGX) | Chief Scientific Officer and Head of Research and Development | $410,000 | $1,618,355 |
Recent activity
No call appearances or filed executive changes recorded yet.